The success of a technology-driven acquisition depends fundamentally on the integrity, enforceability, and transferability of the target’s intellectual property portfolio. During M&A due diligence, IP issues that appear peripheral during early review often emerge as decisive deal breakers once buyer counsel performs confirmatory analysis.
Unlike commercial or operational risks, many IP red flags are not economically “priceable.” Structural defects, statutory violations, or uncurable title gaps frequently force acquirers to abandon transactions entirely, irrespective of strategic fit or headline valuation.
Structural Vulnerabilities in IP Asset Chains
Ownership defects are the most common and the most fatal category of IP red flags in M&A transactions.
Incomplete Chain of Title and Inventor Disconnects
Under the Indian Patents Act, 1970, the right to apply for a patent vests initially in the true and first inventor or their lawful assignee. Corporate ownership is not presumed.
Common failure patterns include:
· Founders filing patents personally and never assigning them to the company
· Contractors or consultants contributing to inventions without execution of invention assignment deeds
· Early development work performed before incorporation, with no confirmatory assignment post-incorporation
Under Section 17 of the Copyright Act, 1957, employment under a contract of service may vest copyright in the employer. This presumption does not extend to patents and does not apply to independent contractors. Where even one contributor retains ownership, the patent becomes unenforceable as a practical matter.
Failure to Record Assignments under Section 68 and 69
Section 68 requires assignments, mortgages, and interests in patents to be in writing. Section 69 requires recordal with the Controller.
Based on current Indian Patent Office practice:
· An unrecorded assignee cannot reliably enforce patent rights
· Courts may refuse to recognize title against third parties
· Buyers treat unrecorded assignments as a material defect, not a clerical omission
Historic M&A transactions frequently reveal that IP acquired in earlier restructurings was never reflected in the Patent Register, creating cascading title failures.
Risks of Unregistered Mortgages and Hypothecation
Security
interests created in favor of lenders often remain uncleared or undisclosed.
Where:
· Charges are registered with the Registrar of Companies but not at the Patent Office, or
· Patent Office records show encumbrances absent from corporate filings
the mismatch signals weak governance and exposes the acquirer to priority disputes.
Freedom to Operate (FTO) and Litigation Exposure
Ownership alone does not confer the right to commercialize technology.
Unmitigated Infringement Risks in Target Product Lines
An acquisition is usually justified by specific products or platforms. If those offerings infringe third-party patents, post-closing injunctions or damages can destroy deal economics.
Acquirers expect evidence of:
· Product-specific FTO analysis
· Identification of blocking patents
· Documented licensing or design-around strategies
Undisclosed cease-and-desist notices or known competitor patents constitute serious disclosure failures.
Invalidity Risks in Core Portfolio Assets
Deal valuation frequently hinges on a small subset of “crown jewel” patents. Where those assets are vulnerable, the entire transaction is undermined.
Impact of Pending Post-Grant Oppositions and IPRs
Active challenges materially cloud title:
· Post-grant oppositions in India
· Inter Partes Reviews before the US PTAB
· Revocation proceedings in Europe
Even defensible challenges often lead to purchase price escrows, deferred consideration, or deal abandonment where the asset is core.
Statutory Non-Compliance as a Deal Breaker
IP rights exist only through statutory compliance. Certain violations are irreversible.
Violations of Section 39: The Foreign Filing License Trap
Section 39 requires Indian residents to obtain a Foreign Filing License before filing patent applications abroad, unless an Indian filing precedes the foreign filing by at least six weeks.
Consequences include:
· Vulnerability to revocation
· Criminal exposure
· Contamination of entire patent families derived from the original filing
Based on publicly available Controller guidance, Section 39 violations are not retrospectively curable. Acquirers treat these as non-mitigable red flags.
Lapsed Patents and Irregular Annuity Payments
Failure to pay renewal fees causes automatic lapse. Restoration under Section 60 is discretionary and time-limited.
Buyers do not assume restoration risk for material assets, particularly where lapses indicate systemic portfolio mismanagement.
Non-Compliance with Form 27 Working Requirements
Persistent non-filing or inconsistent disclosures under Form 27:
· Expose patents to compulsory licensing under Section 84
· Undermine enforcement credibility
· Signal regulatory negligence
Historical non-compliance remains relevant even after procedural simplifications.
Open Source Software (OSS) and Copyleft Contamination
For software-centric acquisitions, OSS issues often represent the highest technical risk.
Viral License Triggers in Proprietary Codebases
Integration of copyleft components such as GPL or AGPL may obligate disclosure of proprietary source code. This destroys trade secret value and compromises exclusivity.
Absence of an OSS audit is itself treated as a red flag.
Remediation Costs and Valuation Adjustments
OSS remediation involves:
· Code refactoring
· Replacement of contaminated modules
· Retesting and redeployment
Buyers typically discount valuation by the projected cost and time required for remediation, often materially.
Encumbrances and Restrictive Licensing Agreements
Contractual constraints frequently override technical ownership.
Change of Control Clauses in In-Licensing Contracts
Licenses from universities, research institutions, or strategic partners often terminate or require consent upon acquisition.
Where licenses are:
· Non-assignable
· Subject to transfer fees
· Terminable if the acquirer is a competitor
the deal rationale may collapse.
Exclusive Out-Licenses as Barriers to Integration
Exclusive licenses granted by the target may prevent post-acquisition use in key territories or verticals. These are particularly damaging where the acquirer’s integration strategy assumes global rollout.
Most Favoured Nation (MFN) and Non-Compete Overhangs
MFN clauses and non-compete covenants can unintentionally apply across the acquirer’s broader business, creating revenue leakage or operational constraints well beyond the target.
Framework for Pre-Transaction IP Due Diligence
Effective diligence focuses on materiality, not volume.
Materiality Thresholds for IP Audit
Material IP typically includes:
· Assets covering more than 20 percent of revenue
· Trademarks in top commercial markets
· Trade secrets essential to manufacturing or performance
Peripheral assets rarely justify deal disruption.
Verification of Trade Secret Protection Protocols
Trade secrets are only enforceable if secrecy is demonstrable. Buyers examine:
· NDAs and confidentiality clauses
· Access control mechanisms
· Exit procedures for technical staff
Absent documented controls, claimed trade secrets are treated as non-assets.
Strategic Mitigation and Deal Structuring
Not all IP red flags are fatal, but mitigation has limits.
Escrows and Indemnities for IP Risks
Where risks are identifiable and bounded, buyers may require:
· Purchase price escrows
· Special IP indemnities
· Survival periods aligned to statutory limitation periods
These mechanisms do not cure defects. They only reallocate risk.
Carve-outs and Asset Purchase vs. Stock Purchase
Asset purchases allow acquirers to isolate clean IP and leave behind contaminated assets or liabilities. This structure is frequently preferred where OSS or litigation risks cannot be fully remediated.
Frequently asked questions (FAQs)
1.
What is the most common IP red flag in Indian M&A deals
Incomplete
inventor and contractor assignments remain the most frequent issue.
2. Are
pending patent applications acceptable in acquisitions
Yes, if
prosecution risk is managed and clearly disclosed.
3. Why
is Section 39 considered deal-fatal
Because
violations are non-curable and can invalidate entire patent families.
4. Can
representations and warranties cover IP invalidity
Rarely. Known
risks are excluded from R&W insurance.
5. How
do buyers treat OSS contamination
Often as a
structural integration blocker rather than a pricing issue.
6. Do
acqui-hires still require clean IP
Yes. The
acquirer must ensure continued lawful development.
7. How
long does IP diligence typically take
Three to six
weeks for a mid-sized technology company.
8.
What is an FTO letter
A legal opinion
assessing infringement risk for specific products.
9. Can
post-closing litigation be shifted to sellers
Only if risks
were undisclosed and contractually covered.
10.
Are SEP risks material in M&A
Yes. Missing
FRAND licenses can create massive post-closing exposure.